Childhood bullous pemphigoid-A case report  by Chen, Chun-Bing et al.
lable at ScienceDirect
DERMATOLOGICA SINICA 34 (2016) 160e161Contents lists avaiDermatologica Sinica
journal homepage: http: / /www.derm-sinica.comCORRESPONDENCEChildhood bullous pemphigoid-A case reportDear Editor,
Bullous pemphigoid (BP) usually affects the elderly, but BP in in-
fancy has also been reported.1 Here, we report our observation in a
case of childhood BP in Taiwan.
A 15-month-old boy presented with recurrent blisters on his
face, trunk, and extremities 1 month later after receiving measles,
mumps, rubella, and varicella vaccination (Figure 1Ae1D). A few
vesicles were also seen on his tongue and oral mucosa, and the
palms and soles were also involved (Figure 1E). Direct and indirect
Nikolsky signs were negative.
Laboratory examinations showed an elevated immunoglobulin
G (IgG) level (1290 mg/dL), low Complement component 3 (C3)
(76.6 mg/dL), and negative ﬁndings for antinuclear antibody. Indi-
rect immunoﬂuorescence testing revealed positive antibasement
membrane zone antibody (1:40) and a negative result for anti-
intercellular substance antibody. Histopathologic examination of
a blister on the left hand revealed a subepidermal bulla containing
neutrophils, eosinophils, and lymphocytes, with papillary edema
and congested dermal vessels surrounded by mononuclear cells
(Figure 2Ae2B). Direct immunoﬂuorescence (DIF) study showed
strong linear deposits of IgG and C3 along the dermoepidermal
junction and weaker IgA and complement component 1, q subcom-
ponent (C1q) deposits, which supported a diagnosis of BP
(Figure 2Ce2D). The patient was admitted to our hospital and the
lesions on the trunk and extremities responded well to systemic
steroid treatment. However, the oral blisters persisted after 3
weeks of intravenous corticosteroid (prednisolone 1e2.5 mg/kg/
d) treatment. A dose of intravenous immunoglobulin (IVIG) with
1.8 g/kg was administered for the refractory oral lesions, after
which the oral mucosa improved. BP was well-controlled by low-
dose systemic steroid use.
BP is an autoimmune bullous disease that is typically seen in the
elderly and is very rare in infants and children.1 The ﬁrst peak oc-
curs more frequently from the 1st year of life (53.2%) and the second
peak was reported at the age of 8 years (8.8%).2 Childhood BP is
more frequent in girls. As in adults, lesions usually begin as urticar-
ial pruritic papules and plaques followed by tense bullae on an
erythematous background. In infancy, BP usually presents with
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It is difﬁcult to diagnosis childhood BP on the basis of clinical
features alone since there are a wide variety of bullous disorders
with similar features.4 The differential diagnosis includes chronic
bullous disease of childhood (or linear IgA bullous dermatosis), epi-
dermolysis bullosa acquisita, bullous arthropod assault reaction,
and bullous systemic lupus erythematosus.4 A BP diagnosis is based
on histopathologic examination and DIF study.3 Examination of bi-
opsy specimens typically reveals subepidermal bullae formation
and a variable number of eosinophils. Deposition of linear IgG
and/or C3 is typically seen on the basementmembrane, andweaker
deposition of IgM, IgA, IgD, and/or IgE is occasionally present. IgM
deposition is more frequently seen in childhood BP than in infant
BP.2 DIF study helps to differentiate BP from linear IgA bullous
dermatosis with linear basement membrane zone IgA deposition
and bullous systemic lupus erythematosus with positive lupus
band test. Indirect immunoﬂuorescence may reveal IgG antibodies
along the epidermal side of salt-split skin in BP. In contrast to BP,
IgG antibodies were deposited along the dermal side in epidermol-
ysis bullosa acquisita.4 Immunoblotting with serum reacts to BP an-
tigens at 180 kDa and 230 kDa.1 Autoantibodies of both the IgA and
IgG class to the noncollagenous 16A (NC16A) domain of 180-kDa
antigen (BP180) were demonstrated in the sera from patients
with childhood BP.5
Systemic corticosteroids are the best initial treatment for child-
hood BP.3 Sulfapyridine, dapsone, and azathioprine are usually used
in combinationwith corticosteroids in refractory cases. IVIG therapy
is a valuable treatment option for intractable BP in both infants and
adults.6 Our patient responded well to a single dose of IVIG for the
persistent oral mucosal involvement. Childhood BP usually has a
good prognosis and remission typically is achieved within weeks to
a fewmonths, although the course is less benign in some children.3,7
BP in infancy has been reported within hours to weeks after
vaccination, including vaccinations for hepatitis B, pneumococcus,
tetanusediphtheriaepertussis, and poliovirus.2,8 BP in adults and
infants was reported to be associated with vaccination, but it is
difﬁcult to establish an association between vaccination and BP in
infancy, because of the high rate of vaccinations during the ﬁrst
year of life.8
In conclusion, we report a case of childhood BP with generalized
blisters 1 month after vaccination. Intractable oral lesions
responded well to IVIG treatment. Although childhood BP is rare,
it should be included in the differential diagnosis of bullous diseaseer Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
Figure 1 (A) Multiple erosive vesicles can be seen on the face, lips, and tongue. (B,C)
Tense vesicles and bullae on erythematous urticarial background presented on geni-
talia and perineum. (D) Erythematous patches with bullae and crusted wounds were
noticed over the neck and axillae. (E) A skin biopsy specimen of a vesicle on the left
hand was collected for histology examination and perilesional direct immunoﬂuores-
cence study.
Figure 2 (A,B) Subepidermal bulla containing neutrophils, eosinophils and lympho-
cytes, papillary edema, and congested dermal vessels surrounded by mononuclear cells
(hematoxylin-eosin stain, original magniﬁcation 200). (C,D) Direct immunoﬂuores-
cence study showed strong linear IgG staining and weaker IgA staining of the base-
ment membrane zone. Ig¼ immunoglobulin.
Correspondence / Dermatologica Sinica 34 (2016) 160e161 161in children. IVIG treatment could be an optional treatment for re-
fractory childhood BP cases.
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